UNSPSC 51343510: Tenofovir df

This classification denotes a reverse transcriptase inhibitor and purine antagonist with the molecular formula C19H30N5O10P.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OTT9J7900I, chemically known as bis(hydroxymethyl) (((r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)phosphonate, bis(isopropyl carbonate) (ester), fumarate (1:1), but more generally known as tenofovir df, which bears US NIH Compound Identifier 6398764.

European Medicines Agency schedules tenofovir df or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04721MIG. Most nations, for tariff purposes, schedule tenofovir df under HS 29335995. SMILES: C[C@H](CN1CNC2C1NCNC2N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.C(=C/C(=O)O)\C(=O)O.

UNSPSC 51343510 Tenofovir df is a Commodity code covering antiviral pharmaceutical products, though recent state and local opportunities tagged under this code show little activity directly aligned with tenofovir procurement. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride — antibiotics, not antivirals — under an Invitation for Bid process with a total contract value of $2,999,999.11 over three years. A second opportunity from Seminole County, Florida, posted in June 2026, sought Naloxone and Safe Drug Deactivation Systems quarterly, commodities outside the antiviral class entirely. State and local governments purchasing under this code appear to use cooperative purchasing vehicles and piggyback arrangements to source pharmaceutical products at volume discounts, with state health departments and county public health agencies as primary buyers.

Recent activity shows procurement spread across Florida and Illinois, though the opportunities on record do not represent solicitations for tenofovir itself. The Seminole County Naloxone procurement, an IFB with a July 2026 response deadline, required quarterly deliveries to the Seminole County Community Health Building and included compliance mandates for drug-free workplace certification, E-Verify, and federal audit requirements tied to potential FEMA funding. The Illinois Department of Public Health contract, completed in August 2026, set a 12-month initial term with two renewal options and included no set-aside or preference designations. Both opportunities reflect state and local health agencies sourcing pharmaceutical commodities through formal bidding with fixed-price models and multi-year terms, but neither directly targets the tenofovir market segment.